MedPath

The effect of adding dexmedetomidine to bupivacaine in paravertebral block.

Phase 4
Conditions
nerve Block.
adverse of therapeutic use
Registration Number
IRCT2015121212642N23
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

ASA I-III; there is no known sensitivity or contraindications for injection of studied drugs; non-prescription tranquilizer in the 24 hours prior to anesthesia; no history of chronic use of opioids or benzodiazepines; no history of liver disease; no history of cardiovascular disease; no history of lung disease; lack the urgency of the surgery.Exclusion criteria: Those who find complicated surgery for any reason; intraoperative hemodynamic disturbances; disturbances in consciousness in the post-operative stage; need to continue mechanical ventilation after the end of anesthesia; complications related to surgery.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of narcotic of injection. Timepoint: In times of 2, 6, 12, 24 and 48 hours after surgery. Method of measurement: The based on question of the floor nurses and based on milligram.;Amount of pain. Timepoint: In times of 2, 6, 12, 24 and 48 hours after surgery. Method of measurement: Based on patient state and show the related shaped VAS ruler.
Secondary Outcome Measures
NameTimeMethod
Amount of Satisfaction. Timepoint: In times of 2, 6, 12, 24 and 48 hours after surgery. Method of measurement: According to the questionnaire, as excellent, good, average, unhappy.
© Copyright 2025. All Rights Reserved by MedPath